The Journal of Medicinal Chemistry publishes studies that contribute to an understanding of the relationship between molecular structure and biological activity or mode of action. Some specific areas that are appropriate include the following: Design, synthesis, and biological evaluation of novel biologically active compounds, diagnostic agents, or labeled ligands employed as pharmacological tools. Molecular modifications of reported series that lead to a significantly improved understanding of their structure-activity relationships (SAR). Routine extensions of existing series that do not utilize novel chemical or biological approaches or do not add significantly to a basic understanding of the SAR of the series will normally not be accepted for publication. Structural biological studies (X-ray, NMR, etc.) of relevant ligands and targets with the aim of investigating molecular recognition processes in the action of biologically active compounds. Molecular biological studies (e.g., site-directed mutagenesis) of macromolecular targets that lead to an improved understanding of molecular recognition. Computational studies that provide fresh insight into the SAR of compound series that are of current general interest or analysis of other available data that subsequently advance medicinal chemistry knowledge. Substantially novel computational chemistry methods with demonstrated value for the identification, optimization, or target interaction analysis of bioactive molecules. Effect of molecular structure on the distribution, pharmacokinetics, and metabolic transformation of biologically active compounds. This may include design, synthesis, and evaluation of novel types of prodrugs. Novel methodology with broad application to medicinal chemistry, but only if the methods have been tested on relevant molecules.
Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER).
来源期刊:Journal of medicinal chemistry
DOI:10.1021/ACS.JMEDCHEM.8B01572
Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects.
来源期刊:Journal of medicinal chemistry
DOI:10.1021/acs.jmedchem.8b01210
Novel Allosteric Activators for Ferroptosis Regulator Glutathione Peroxidase 4.
来源期刊:Journal of medicinal chemistry
DOI:10.1021/acs.jmedchem.8b00315
A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity.
来源期刊:Journal of medicinal chemistry
DOI:10.1021/acs.jmedchem.9b00723
Antimicrobial Peptides with High Proteolytic Resistance for Combating Gram-Negative Bacteria.
来源期刊:Journal of medicinal chemistry
DOI:10.1021/acs.jmedchem.8b01348
已经到底了~
测一测你投这本期刊的成功率
【官方推荐】国内首个期刊投稿预测系统,多维度分析投稿成功率,助你精准决策
13089
人已预测
鹿粉19527
2025-09-22 23:35:07
我投JOURNAL OF MEDICINAL CHEMISTRY,录用周期平均才2.1个月,审稿流程快,很适合着急出成果的科研人,冲就完事儿!